reovirus


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

re·o·vi·rus

 (rē′ō-vī′rəs)
n. pl. re·o·vi·rus·es
Any of a family of viruses that contain double-stranded RNA and are associated with various diseases in animals, including human respiratory and gastrointestinal infections.

reovirus

(ˈriːəʊˌvaɪərəs)
n
any member of the family of viruses Reoviridae, characterized by double-stranded RNA and found in the respiratory and digestive systems of vertebrates

re•o•vi•rus

(ˌri oʊˈvaɪ rəs, ˈri oʊˌvaɪ-)

n., pl. -rus•es.
any of several large viruses of the family Reoviridae having double-stranded RNA and a polyhedral capsid: includes viruses that cause gastroenteritis.
[1955–60; r(espiratory)e(nteric)o(rphan)virus]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.reovirus - any of a group of non-arboviruses including the rotavirus causing infant enteritis
animal virus - an animal pathogen that is a virus
rotavirus - the reovirus causing infant enteritis
References in periodicals archive ?
A newly discovered viral pathogen of Asian citrus psyllid (AsCP), Diaphorina citri Kuwayama (Hemiptera: Psyllidae), was classified as a reovirus. The AsCP is an efficient vector of the plant-infecting bacterium ("Candidatus Liberibacter asiaticus") associated with the disease Huanglongbing, which has caused extensive economic losses to citrus industries world-wide.
The viruses and cells used were herpes simplex virus type 1 (HSV-1) (strain KOS), herpes simplex virus type 2 (HSV-2) (strain G), vaccinia virus, vesicular stomatitis virus, and thymidine-kinase-deficient HSV-1 ([TK.sup.-]) (strain KOS) in HEL cells; vesicular stomatitis virus, Coxsackie virus B4, respiratory syncytial virus in HeLa cells; parainfluenza virus type 3, reovirus type 1, Sindbis virus, Coxsackie B4 virus and Punta Toro virus in Vero cells; and HIV-1 ([III.sub.B]) and HIV-2 (strain ROD) in human T-lymphocyte (CEM) cells (at compound concentrations up to 100 [micro]g/ml).
En ratones se han asociado con el desarrollo de T1D los virus de la Encefalomiocarditis (EMC) (37, 38), los mengovirus (39), los reovirus (40) y algunos retrovirus; Coxsackie B virus, particularmente B4, en ratones (41-43) y primates no humanos (44); virus de la rubeola en hamsters y conejos (30, 45); virus de enfermedad mucosodiarreica viral bovina en cabras (46), y KRV (Virus Kilham de la rata) en ratas (47, 48).
They also focus on the activation and evasion of host antiviral signaling pathways by detailing RNA virus families, filoviruses, suppression of innate immunity, paramyxovirus and orthomyxoviruses, arenaviruses, picornaviruses, togaviruses, coronaviruses and innate immune responses elicited by reovirus and rotavirus.
(Calgary, Canada) announced that it has been granted its 31st United States Patent 7,476,382, entitled "Reovirus for the Treatment of Neoplasia." The patent includes claims to pharmaceutical compositions containing reovirus.
Other viruses that may be involved include canine adenovirus, reovirus, and the canine herpes virus.
En Venezuela, la incidencia de enfermedades respiratorias virales e inmunosupresoras son dos de los mayores problemas en la industria avicola nacional, y hasta el momento no se cuenta con suficiente informacion epidemiologica al respecto que ayude a establecer medidas de control, por lo que el objetivo de esta investigacion fue determinar serologicamente la presencia de anemia infecciosa aviar, reovirus y gumboro, y su relacion entre ellas, asi como determinar el nivel de anemia en las aves evaluadas.
Viral Reovirus Parasitario - Ectoparasitismos severos por garrapatas, o acaros.
It has also been used to capture samples for RT-PCR detection of avian reovirus and plant viruses.
REOVIRUS SEROTYPE-DEPENDENT CHEMOKINE AND REPLICATION DIFFERENCES IN A HUMAN MONOCYTE CELL LINE.
The MSU M Cell vaccine technology that has been licensed by LigoCyte is based on the targeting of mucosal M cells using a protein isolated from reovirus. This targeting protein allows vaccines to be delivered directly into mucosal inductive sites, resulting in a greatly enhanced response by the immune system.
SYNSORB maintains approximately 39% of the shares of Oncolytics, a company focused on the development of REOLYSIN (reovirus) as a potential cancer therapeutic.